tazarotene has been researched along with Nail Diseases in 14 studies
tazarotene: a topical acetylenic retinoid; a topical kerytolytic
tazarotene : The ethyl ester of tazarotenic acid. A prodrug for tazarotenic acid, it is used for the treatment of psoriasis, acne, and sun-damaged skin.
Nail Diseases: Diseases of the nail plate and tissues surrounding it. The concept is limited to primates.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy and safety of FCL plus topical tazarotene versus tazarotene monotherapy in the treatment of nail psoriasis." | 9.51 | Efficacy of combined fractional carbon dioxide laser and topical tazarotene in nail psoriasis treatment: A randomized intrapatient left-to-right study. ( Essa Abd Elazim, N; Mahmoud Abdelsalam, A; Mohamed Awad, S, 2022) |
| "Tazarotene is a topically-applied, receptor-selective retinoid that has been shown to modulate several major pathogenic factors of psoriasis." | 7.80 | Periungual pyogenic granulomas due to topical tazarotene for nail psoriasis. ( Patrizi, A; Piraccini, BM; Venturi, M, 2014) |
| "Our study shows the therapeutic potential of tazarotene ointment in nail psoriasis." | 7.78 | Nail psoriasis: treatment with tazarotene 0.1% hydrophilic ointment. ( Collgros, H; Expósito-Serrano, V; Fischer-Levancini, C; Llambí, F; Sánchez-Regaña, M; Umbert-Millet, P, 2012) |
| "The tazarotene treatment resulted in a significantly greater reduction in onycholysis in occluded nails (P < or = ." | 6.70 | Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study. ( Scher, RK; Stiller, M; Zhu, YI, 2001) |
| "To evaluate the efficacy and safety of FCL plus topical tazarotene versus tazarotene monotherapy in the treatment of nail psoriasis." | 5.51 | Efficacy of combined fractional carbon dioxide laser and topical tazarotene in nail psoriasis treatment: A randomized intrapatient left-to-right study. ( Essa Abd Elazim, N; Mahmoud Abdelsalam, A; Mohamed Awad, S, 2022) |
| "Tazarotene is a topically-applied, receptor-selective retinoid that has been shown to modulate several major pathogenic factors of psoriasis." | 3.80 | Periungual pyogenic granulomas due to topical tazarotene for nail psoriasis. ( Patrizi, A; Piraccini, BM; Venturi, M, 2014) |
| "Our study shows the therapeutic potential of tazarotene ointment in nail psoriasis." | 3.78 | Nail psoriasis: treatment with tazarotene 0.1% hydrophilic ointment. ( Collgros, H; Expósito-Serrano, V; Fischer-Levancini, C; Llambí, F; Sánchez-Regaña, M; Umbert-Millet, P, 2012) |
| "Nail psoriasis is difficult to treat." | 2.78 | Efficacy of pulsed dye laser plus topical tazarotene versus topical tazarotene alone in psoriatic nail disease: a single-blind, intrapatient left-to-right controlled study. ( Chiang, YY; Chou, CL; Huang, YC, 2013) |
| "The tazarotene treatment resulted in a significantly greater reduction in onycholysis in occluded nails (P < or = ." | 2.70 | Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study. ( Scher, RK; Stiller, M; Zhu, YI, 2001) |
| "Psoriasis is a chronic skin disease that affects millions of people throughout the world." | 2.44 | Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. ( Jiaravuthisan, MM; Muhn, CY; Murphy, F; Sasseville, D; Vender, RB, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (64.29) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Essa Abd Elazim, N | 1 |
| Mahmoud Abdelsalam, A | 1 |
| Mohamed Awad, S | 1 |
| Huang, YC | 1 |
| Chou, CL | 1 |
| Chiang, YY | 1 |
| Piraccini, BM | 1 |
| Venturi, M | 1 |
| Patrizi, A | 1 |
| Sherber, NS | 1 |
| Hoch, AM | 1 |
| Coppola, CA | 1 |
| Carter, EL | 1 |
| Chang, HL | 1 |
| Barsanti, FR | 1 |
| Mackay-Wiggan, JM | 1 |
| Fischer-Levancini, C | 1 |
| Sánchez-Regaña, M | 1 |
| Llambí, F | 1 |
| Collgros, H | 1 |
| Expósito-Serrano, V | 1 |
| Umbert-Millet, P | 1 |
| Kroiss, MM | 1 |
| Vogt, T | 1 |
| Finkenzeller, T | 1 |
| Landthaler, M | 1 |
| Stolz, W | 1 |
| Bianchi, L | 2 |
| Soda, R | 2 |
| Diluvio, L | 2 |
| Chimenti, S | 3 |
| Hagman, JH | 1 |
| Ginebri, A | 1 |
| Mordenti, C | 1 |
| De Simoni, I | 1 |
| Rigopoulos, D | 1 |
| Gregoriou, S | 1 |
| Katsambas, A | 1 |
| Prevost, NM | 1 |
| English, JC | 1 |
| Waller, JM | 1 |
| Wu, JJ | 1 |
| Murase, JE | 1 |
| Dyson, SW | 1 |
| Kelly, KM | 1 |
| Jiaravuthisan, MM | 1 |
| Sasseville, D | 1 |
| Vender, RB | 1 |
| Murphy, F | 1 |
| Muhn, CY | 1 |
| Scher, RK | 1 |
| Stiller, M | 1 |
| Zhu, YI | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Combined Fractional Carbon Dioxide Laser and Topical Tazarotene in the Treatment of Psoriatic: Nail Disease a Single-blind, Intrapatient Left-to-right Controlled Study.[NCT03263624] | Phase 4 | 30 participants (Anticipated) | Interventional | 2017-10-01 | Not yet recruiting | ||
| Subclinical Nail Involvement in Relevant Skin Diseases[NCT04092413] | 384 participants (Anticipated) | Observational | 2019-11-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for tazarotene and Nail Diseases
| Article | Year |
|---|---|
Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Clinical Trials as Topic; Cyclosporine; | 2007 |
Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Clinical Trials as Topic; Cyclosporine; | 2007 |
Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Clinical Trials as Topic; Cyclosporine; | 2007 |
Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Clinical Trials as Topic; Cyclosporine; | 2007 |
5 trials available for tazarotene and Nail Diseases
| Article | Year |
|---|---|
Efficacy of combined fractional carbon dioxide laser and topical tazarotene in nail psoriasis treatment: A randomized intrapatient left-to-right study.
Topics: Dermatologic Agents; Humans; Lasers, Gas; Nail Diseases; Nicotinic Acids; Psoriasis; Treatment Outco | 2022 |
Efficacy of pulsed dye laser plus topical tazarotene versus topical tazarotene alone in psoriatic nail disease: a single-blind, intrapatient left-to-right controlled study.
Topics: Administration, Topical; Adult; Aged; Combined Modality Therapy; Dermatologic Agents; Drug Administr | 2013 |
Tazarotene 0.1% gel for psoriasis of the fingernails and toenails: an open, prospective study.
Topics: Adult; Aged; Dermatologic Agents; Female; Humans; Male; Middle Aged; Nail Diseases; Nicotinic Acids; | 2003 |
Treatment of psoriatic nails with tazarotene cream 0.1% vs. clobetasol propionate 0.05% cream: a double-blind study.
Topics: Administration, Topical; Clobetasol; Dermatologic Agents; Double-Blind Method; Humans; Keratolytic A | 2007 |
Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study.
Topics: Adult; Dermatologic Agents; Double-Blind Method; Drug Evaluation; Female; Fingers; Gels; Humans; Mal | 2001 |
8 other studies available for tazarotene and Nail Diseases
| Article | Year |
|---|---|
Periungual pyogenic granulomas due to topical tazarotene for nail psoriasis.
Topics: Administration, Cutaneous; Adult; Aged; Dermatologic Agents; Female; Granuloma, Pyogenic; Humans; Ma | 2014 |
Efficacy and safety study of tazarotene cream 0.1% for the treatment of brittle nail syndrome.
Topics: Administration, Topical; Aged; Female; Humans; Keratolytic Agents; Male; Middle Aged; Nail Diseases; | 2011 |
Nail psoriasis: treatment with tazarotene 0.1% hydrophilic ointment.
Topics: Dermatologic Agents; Humans; Nail Diseases; Nicotinic Acids; Ointments; Psoriasis | 2012 |
[Psoriatic onycho-pachydermo- periostitis].
Topics: Adult; Antirheumatic Agents; Arthritis, Psoriatic; Diagnosis, Differential; Drug Therapy, Combinatio | 2002 |
Treatment of occupational koilonychia with tazarotene gel.
Topics: Administration, Cutaneous; Construction Materials; Dermatitis, Occupational; Dermatologic Agents; Ge | 2003 |
Treatment of trachyonychia with tazarotene.
Topics: Adult; Alopecia Areata; Humans; Keratolytic Agents; Male; Nail Diseases; Nicotinic Acids | 2005 |
Palliative treatment of fingernail lichen planus.
Topics: Administration, Topical; Aged; Clobetasol; Drug Therapy, Combination; Female; Gels; Humans; Lichen P | 2007 |
Chronically painful right thumb with pustules and onycholysis. Diagnosis: acrodermatitis continua of Hallopeau.
Topics: Acrodermatitis; Aged; Chronic Disease; Dermatologic Agents; Diagnosis, Differential; Female; Humans; | 2007 |